(Q44807639)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

title

Raltitrexed plus weekly oxaliplatin as first-line chemotherapy in metastatic colorectal cancer: a multicenter non-randomized phase ii study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

1 reference

1 reference

metastatic colon cancer

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Bruno Vincenzi

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Giuseppe Tonini

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Rolando D'Angelillo

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

2

Cristian Massacesi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

9

Maurizio Bonsignori

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

4

Fabiana Marcucci

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

7

Alberta Pilone

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

author name string

Costantino Campisi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

Vincenzo Bianco

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

publication date

1 January 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

26 December 2019

page(s)

59-66

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15034215%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1385/mo:21:1:59

26 December 2019

exact match

0 references

cites work

Oxaliplatin plus raltitrexed in patients with advanced colorectal carcinoma: results of a Phase I-II trial

1 reference

12 December 2020

Phase III multicenter randomized trial of oxaliplatin added to chronomodulated fluorouracil-leucovorin as first-line treatment of metastatic colorectal cancer

1 reference

12 December 2020

Multicenter non-randomized phase II study of raltitrexed (Tomudex) and oxaliplatin in non-pretreated metastatic colorectal cancer patients.

1 reference

12 December 2020

Phase I, dose-finding, and pharmacokinetic study of raltitrexed combined with oxaliplatin in patients with advanced cancer

1 reference

12 December 2020

Combination of raltitrexed and oxaliplatin is an active regimen in malignant mesothelioma: results of a phase II study

1 reference

12 December 2020

Raltitrexed plus oxaliplatin (TOMOX) as first-line chemotherapy for metastatic colorectal cancer. A phase II study of the Italian Group for the Study of Gastrointestinal Tract Carcinomas (GISCAD).

1 reference

12 December 2020

Second-line treatment with oxaliplatin + raltitrexed in patients with advanced colorectal cancer failing fluoropyrimidine/leucovorin-based chemotherapy

1 reference

12 December 2020

Raltitrexed plus oxaliplatin as first-line chemotherapy in metastatic colorectal carcinoma: a multicentric phase II trial

1 reference

12 December 2020

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer

1 reference

12 December 2020

A prospective randomized trial of 5-fluorouracil versus 5-fluorouracil and high-dose leucovorin versus 5-fluorouracil and methotrexate in previously untreated patients with advanced colorectal carcinoma

1 reference

12 December 2020

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group

1 reference

12 December 2020

Raltitrexed: current clinical status and future directions

1 reference

12 December 2020

Irinotecan combined with bolus 5-fluorouracil and folinic acid Nordic schedule as first-line therapy in advanced colorectal cancer

1 reference

12 December 2020

Reporting results of cancer treatment

1 reference

12 December 2020

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

1 reference

12 December 2020

Therapeutic advances in the management of metastatic colorectal cancer

1 reference

12 December 2020

Survival and response to chemotherapy for advanced colorectal adenocarcinoma: an Eastern Cooperative Oncology Group report

1 reference

12 December 2020

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer

1 reference

12 December 2020